Ivabradine is indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, ...

Fintel reports that on November 12, 2024, Alembic Global upgraded their outlook for BWX Technologies (NYSE:BWXT) from Neutral ...

Alembic Pharmaceuticals Q2 Results Live : Alembic Pharmaceuticals declared their Q2 results on 07 Nov, 2024, reporting a ...

Alembic Pharmaceuticals Ltd has secured final approval from the USFDA for its generic Diltiazem Hydrochloride ...

Alembic Pharmaceuticals Limited announced today it has received final approval from the US Food & Drug Administration (USFDA) ...

Alembic Pharmaceuticals received final USFDA approval for its generic Diltiazem Hydrochloride extended-release capsules, designed to treat hypertension. Available in multiple strengths, these capsules ...

These capsules will be available in dosages of 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg, offering a generic alternative to ...

Alembic Global Advisors upgraded shares of BWX Technologies (NYSE:BWXT – Free Report) from a neutral rating to an overweight rating in a research report sent to investors on Tuesday, MarketBeat ...

Alembic Global analyst Pete Skibitski upgraded BWX Technologies (BWXT) to Overweight from Neutral with a $148 price target Published first on ...

Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic ...

The authorised ANDA is a therapeutic equivalent of the reference-listed drug (RLD), Corlanor tablets, in the same 5 mg and ...

Alembic Pharmaceuticals stated that it gained final FDA approval for the Diltiazem Hydrochloride Extended-Release capsules, ...